NM_181523.3:c.1425+2T>A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_181523.3(PIK3R1):c.1425+2T>A variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_181523.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIK3R1 | NM_181523.3 | c.1425+2T>A | splice_donor_variant, intron_variant | Intron 11 of 15 | ENST00000521381.6 | NP_852664.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.1425+2T>A intronic variant results from a T to A substitution two nucleotides after exon 11 (coding exon 10) of the PIK3R1 gene. Alterations that disrupt the canonical splice site are expected to result in aberrant splicing. The resulting transcript is predicted to be in-frame and is not expected to trigger nonsense-mediated mRNA decay. for PIK3R1-related immunodeficiency; however, its clinical significance for SHORT syndrome is uncertain This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been reported in multiple individuals and was determined to be de novo in at least one individual with features consistent with PIK3R1-related immunodeficiency (Elkaim, 2016; Olbrich, 2016). Other alterations impacting the same donor site (c.1425+1G>C, c.1425+1G>A) have been shown to have a similar impact on splicing in individuals with hyper IgM syndrome, lymphadenopathy, and short stature (Lucas, 2014; Deau, 2014; Petrovski, 2016). This nucleotide position is highly conserved in available vertebrate species. RNA studies have demonstrated that this alteration results in abnormal splicing (Elkaim, 2016; Olbrich, 2016). In silico splice site analysis predicts that this alteration will weaken the native splice donor site. Based on the available evidence, this alteration is classified as pathogenic. -
SHORT syndrome;C3554689:Agammaglobulinemia 7, autosomal recessive;C4014934:Immunodeficiency 36 Pathogenic:1
This sequence change affects a donor splice site in intron 11 of the PIK3R1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with clinical features of PIK3R1-related conditions (PMID: 25133428, 28104464). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 446497). Studies have shown that disruption of this splice site results in skipping of exon 11 (also known as exon 10 due to alternative exon numbering), but is expected to preserve the integrity of the reading-frame (PMID: 25133428). For these reasons, this variant has been classified as Pathogenic. -
Immunodeficiency 36 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at